Les Echos, Capital Finance – La biotech Enyo Pharma sécurise 40 M€ pour sa série B

https://capitalfinance.lesechos.fr/deals/capital-risque/la-biotech-enyo-pharma-securise-40-m-pour-sa-serie-b-127458

Published on 05/06/2018

Le Figaro – Pharmacie: Enyo lève 40 millions d’euros

http://www.lefigaro.fr/flash-eco/2018/06/04/97002-20180604FILWWW00190-pharmacie-enyo-leve-40-millions-d-euros.php

Published on 05/06/2018

Challenges – Levée de fonds record pour Enyo Pharma, la biotech lyonnaise qui s’attaque à la malbouffe

https://www.challenges.fr/start-up/levee-de-fonds-record-pour-enyo-pharma-la-biotech-lyonnaise-qui-s-attaque-a-la-malbouffe_591696

Published on 04/06/2018

Le Progrès – Enyo Pharma lève 40 millions d’euros

https://www.leprogres.fr/economie/2018/06/04/enyo-pharma-leve-40-millions-d-euros

Published on 04/06/2018

ENYO Pharma raises €40 million in Series B fundraising

Lyon, June 4, 2018 – ENYO Pharma, a clinical stage biotech company developing innovative drug candidates by mimicking virus strategies to modulate host cellular functions, today announced that it has completed a €40 million Series B round of financing from US and European investors. This new funding will enable the company to finance the two first Phase II clinical trial of its EYP001 asset in both chronic HBV and NASH. A second asset is also planned to enter clinic by 2019.

Read more »

Published on 04/06/2018